Skip to main content
    E

    enVVeno Medical Corp (NVNO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.95
    -0.23 (-3.65%)

    Market Cap: $4.29M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    enVVeno Medical Corp (NVNO) Earnings: Report Dates and Results

    Updated Oct 29, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    enVVeno Medical (NVNO) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, enVVeno Medical reported EPS of -$6.29, below the -$3.27 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    47%(14/30)
    Avg Surprise
    -30.19%

    Upcoming Estimates

    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.86
    Range-$1.86 - -$1.86
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$1.86
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    NVNO has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, NVNO beat 14, missed 14 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 650.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$6.29-$3.27-$3.27 - -$3.27-92.35%MissN/A10 up, 1 downOct 29, 2026N/A
    Jun 30, 2026-$5.37-$4.69-$4.69 - -$4.69-14.50%MissN/A10 up, 1 downJul 30, 2026N/A
    Mar 31, 2026-$5.89-$8.40N/A+29.88%BeatN/AN/AN/AMay 7, 2026N/A
    Dec 31, 2025-$5.91-$0.28-$0.28 - -$0.28N/AN/AN/A10 up, 1 downMar 26, 2026N/A
    Sep 30, 2025-$0.23-$0.30-$0.30 - -$0.30+23.33%BeatN/A11 up, 0 downOct 31, 2025N/A
    Jun 30, 2025-$11.55-$9.80N/A-17.86%MissN/A11 up, 0 downJul 31, 2025N/A
    Mar 31, 2025-$0.22-$0.34-$0.34 - -$0.34+35.29%BeatN/A10 up, 1 downApr 30, 2025N/A
    Dec 31, 2024-$10.50-$12.25N/A+14.29%BeatN/A10 up, 1 downFeb 27, 2025$812000
    Sep 30, 2024-$12.25-$11.55N/A-6.06%MissN/A10 up, 0 downOct 30, 2024N/A
    Jun 30, 2024-$10.85-$12.60N/A+13.89%BeatN/A10 up, 0 downJul 31, 2024N/A
    Mar 31, 2024-$10.85-$14.00N/A+22.50%BeatN/A10 up, 0 downMay 8, 2024N/A
    Dec 31, 2023-$0.36-$0.46-$0.46 - -$0.46+21.74%BeatN/A10 up, 0 downFeb 29, 2024$824000
    Sep 30, 2023-$15.75-$16.80N/A+6.25%BeatN/A11 up, 0 downOct 26, 2023N/A
    Jun 30, 2023-$20.30-$17.15N/A-18.37%MissN/A10 up, 0 downJul 31, 2023N/A
    Mar 31, 2023-$19.95-$16.80N/A-18.75%MissN/A10 up, 0 downMay 1, 2023N/A
    Dec 31, 2022-$0.55-$0.57N/A+3.51%BeatN/AN/A0 up, 0 downMar 2, 2023N/A
    Sep 30, 2022-$18.90-$18.20N/A-3.85%MissN/A10 up, 0 downOct 27, 2022N/A
    Jun 30, 2022-$22.05-$11.55N/A-90.91%MissN/A10 up, 0 downAug 3, 2022N/A
    Mar 31, 2022-$0.47-$0.29-$0.29 - -$0.29-62.07%MissN/A10 up, 0 downApr 29, 2022N/A
    Dec 31, 2021-$32.90-$11.55N/A-184.85%MissN/AN/A0 up, 0 downMar 28, 2022N/A
    Sep 30, 2021-$9.10-$11.90N/A+23.53%BeatN/A1N/ANov 12, 2021N/A
    Jun 30, 2021-$9.80-$11.90N/A+17.65%BeatN/AN/AN/AAug 11, 2021N/A
    Mar 31, 2021-$0.48-$0.34N/A-41.18%MissN/AN/AN/AMay 12, 2021N/A
    Dec 31, 2020-$257.25-$34.30N/A-650.00%MissN/AN/AN/AMar 31, 2021$31243
    Sep 30, 2020-$70.00-$43.75N/A-60.00%MissN/AN/AN/ANov 17, 2020N/A
    Jun 30, 2020-$0.08N/AN/AN/AN/AN/AN/AN/AAug 14, 2020N/A
    Mar 31, 2020-$0.06N/AN/AN/AN/AN/AN/AN/AJun 8, 2020N/A
    Dec 31, 2019-$113.75-$113.75N/A0.00%In lineN/AN/AN/AMar 18, 2020N/A
    Sep 30, 2019-$87.50-$122.50N/A+28.57%BeatN/AN/AN/AOct 31, 2019N/A
    Jun 30, 2019-$0.13-$0.11N/A-18.18%MissN/AN/AN/AAug 5, 2019N/A
    Mar 31, 2019-$0.13-$0.27N/A+51.85%BeatN/AN/AN/AJun 13, 2019$31243
    Dec 31, 2018-$0.28-$0.28N/A0.00%In line-1500.0%N/AN/AMar 13, 2019$30462
    Sep 30, 2018-$0.13-$0.68N/A+80.88%BeatN/AN/AN/ANov 7, 2018$41662
    Jun 30, 2018-$1.06N/AN/AN/AN/AN/AN/AN/AAug 10, 2018$83363
    Mar 31, 2018-$0.11N/AN/AN/AN/AN/AN/AN/AMay 22, 2018$31065
    Dec 31, 2017$0.02N/AN/AN/AN/AN/AN/AN/AMar 31, 2018$175123
    Sep 30, 2017-$0.21N/AN/AN/AN/AN/AN/AN/ADec 14, 2017$27880
    Jun 30, 2017-$0.12N/AN/AN/AN/AN/AN/AN/ASep 7, 2017$38800
    Last 38 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$17.91, after -$44.45 the year before. It was -$0.31 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$17.91N/A
    Dec 31, 2024-$44.45N/A
    Dec 31, 2023-$56.36N/A
    Dec 31, 2022-$41.97N/A
    Dec 31, 2021-$52.28N/A
    Dec 31, 2020-$327.39N/A
    Dec 31, 2019-$201.51N/A
    Dec 31, 2018-$1.58N/A
    Dec 31, 2017-$0.31N/A

    Frequently Asked Questions About NVNO

    When is enVVeno Medical's next earnings date?

    enVVeno Medical's next earnings report is expected for Mar 24, 2027.

    Did NVNO beat earnings estimates last quarter?

    No. enVVeno Medical reported EPS of -$6.29 for the quarter ended Sep 30, 2026, below the -$3.27 estimate by 92.35%.

    What EPS do analysts expect from NVNO next quarter?

    The consensus EPS estimate for enVVeno Medical for the quarter ending Mar 31, 2027 is -$1.86 from 1 analyst, with estimates from -$1.86 to -$1.86.

    How often does NVNO beat earnings estimates?

    enVVeno Medical beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -3.50%.